SNST (Aphex BioCleanse Systems) LT-Debt-to-Total-Asset: 0.00 (As of . 20)


What is Aphex BioCleanse Systems LT-Debt-to-Total-Asset?

Aphex BioCleanse Systems SNST LT-Debt-to-Total-Asset is 0.00 as of . 20.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Aphex BioCleanse Systems's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Aphex BioCleanse Systems's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

Aphex BioCleanse Systems  (OTCPK:SNST) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Aphex BioCleanse Systems LT-Debt-to-Total-Asset Related Terms

Aphex BioCleanse Systems LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems LT-Debt-to-Total-Asset Chart

Aphex BioCleanse Systems Annual Data
Trend
LT-Debt-to-Total-Asset

Aphex BioCleanse Systems Quarterly Data
LT-Debt-to-Total-Asset

Aphex BioCleanse Systems LT-Debt-to-Total-Asset Calculation

Aphex BioCleanse Systems's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Aphex BioCleanse Systems's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Aphex BioCleanse Systems (SNST) has a LT-Debt-to-Total-Asset of 0.00 as of . 20. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' LT-Debt-to-Total-Asset too high?
Aphex BioCleanse Systems' current LT-Debt-to-Total-Asset is 0.00.
How does Aphex BioCleanse Systems' LT-Debt-to-Total-Asset compare to competitors?
Aphex BioCleanse Systems' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Consumer Packaged Goods company?
A good LT-Debt-to-Total-Asset depends on the Consumer Packaged Goods industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Aphex BioCleanse Systems and its competitors. Aphex BioCleanse Systems's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.